If you made any changes in Pure these will be visible here soon.

Research Output 2000 2020

2020

Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis

Basset, M., Defrancesco, I., Milani, P., Nuvolone, M., Rattotti, S., Foli, A., Mangiacavalli, S., Varettoni, M., Benvenuti, P., Cartia, C. S., Paulli, M., Merlini, G., Arcaini, L. & Palladini, G., Jan 23 2020, In : Blood. 135, 4, p. 293-296 4 p.

Research output: Contribution to journalArticle

2019
Monoclonal Gammopathy of Undetermined Significance
Waldenstrom Macroglobulinemia
Lymphoproliferative Disorders
Immunoglobulin M
Blood Proteins

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D'Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Feb 2019, In : Annals of Hematology. 98, 2, p. 361-367 7 p.

Research output: Contribution to journalArticle

Salvage Therapy
Multiple Myeloma
Therapeutics
Recurrence
Drug Combinations

Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice

Cocito, F., Mangiacavalli, S., Valeria Ferretti, V., Cartia, C. S., Ganzetti, M., Benveuti, P., Pompa, A., Catalano, M., Fugazza, E., Landini, B., Arcaini, L. & Corso, A., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Multiple Myeloma
Bone Marrow
Light
Plasma Cells
Serum

Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice: Leukemia and Lymphoma

Cocito, F., Mangiacavalli, S., Ferretti, V. V., Cartia, C. S., Ganzetti, M., Benveuti, P., Pompa, A., Catalano, M., Fugazza, E., Landini, B., Arcaini, L. & Corso, A., 2019, In : Leuk. Lymphoma. 60, 12, p. 2968-2974 7 p.

Research output: Contribution to journalArticle

2018

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D'Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Oct 23 2018, In : Annals of Hematology.

Research output: Contribution to journalArticle

Salvage Therapy
Multiple Myeloma
Therapeutics
Recurrence
Drug Combinations

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Musto, P., Simeon, V., Cascavilla, N., Falcone, A., Petrucci, M. T., Cesini, L., Di Raimondo, F., Conticello, C., Ria, R., Catalano, L., Salvatore, D., Mastrullo, L., Gagliardi, A., Villani, O., Pietrantuono, G., D’Arena, G., Mansueto, G., Bringhen, S., Genuardi, M., Di Renzo, N. & 8 others, Reddiconto, G., Fragasso, A., Caravita, T., Scapicchio, D., Marziano, G., Boccadoro, M., Mangiacavalli, S. & Corso, A., Jan 1 2018, (Accepted/In press) In : Annals of Hematology.

Research output: Contribution to journalArticle

Salvage Therapy
Multiple Myeloma
Therapeutics
Recurrence
Drug Combinations

The advantages of switch to subcutaneous bortezomib in the real life

Mangiacavalli, S., Cocito, F., Ferretti, V. V., Ganzetti, M., Cartia, C. S. & Corso, A., Jun 2018, In : Leukemia and Lymphoma. 59, 6, p. 1505-1507 3 p.

Research output: Contribution to journalArticle

2017

The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity

Oliva, L., Orfanelli, U., Resnati, M., Raimondi, A., Orsi, A., Milan, E., Palladini, G., Milani, P., Cerruti, F., Cascio, P., Casarini, S., Rognoni, P., Touvier, T., Marcatti, M., Ciceri, F., Mangiacavalli, S., Corso, A., Merlini, G. & Cenci, S., Apr 13 2017, In : Blood. 129, 15, p. 2132-2142 11 p.

Research output: Contribution to journalArticle

Proteasome Inhibitors
Plasma Cells
Toxicity
Plasmas
Light

The possible role of burden of therapy on the risk of myeloma extramedullary spread

Mangiacavalli, S., Pompa, A., Ferretti, V., Klersy, C., Cocito, F., Varettoni, M., Cartia, C. S., Cazzola, M. & Corso, A., Jan 1 2017, In : Annals of Hematology. 96, 1, p. 73-80 8 p.

Research output: Contribution to journalArticle

Recurrence
Therapeutics
Multiple Myeloma
Cohort Studies
Multivariate Analysis
2016

Implemented myeloma management with whole-body low-dose CT scan: a real life experience

Mangiacavalli, S., Pezzatti, S., Rossini, F., Doni, E., Cocito, F., Bolis, S. & Corso, A., Jan 20 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

Life Change Events
Incidental Findings
Bone and Bones
Plasmacytoma
Hypercalcemia

The possible role of burden of therapy on the risk of myeloma extramedullary spread

Mangiacavalli, S., Pompa, A., Ferretti, V., Klersy, C., Cocito, F., Varettoni, M., Cartia, C. S., Cazzola, M. & Corso, A., Oct 21 2016, (Accepted/In press) In : Annals of Hematology. p. 1-8 8 p.

Research output: Contribution to journalArticle

Recurrence
Therapeutics
Multiple Myeloma
Cohort Studies
Multivariate Analysis
2015
2014

Correction: Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: A cost-effectiveness analysis (PLoS ONE)

Corso, A., Mangiacavalli, S., Cocito, F., Pascutto, C., Ferretti, V. V., Pompa, A., Ciampichini, R., Pochintesta, L. & Mantovani, L. G., Jan 8 2014, In : PLoS One. 9, 1

Research output: Contribution to journalArticle

Psychological care of caregivers, nurses and physicians: a study of a new approach

Abeni, M. S., Magni, M., Conte, M., Mangiacavalli, S., Pochintesta, L., Vicenzi, G., Ferretti, V. V., Pompa, A., Cocito, F., Klersy, C. & Corso, A., Feb 1 2014, In : Cancer Medicine. 3, 1, p. 101-110 10 p.

Research output: Contribution to journalArticle

Caregivers
Nurses
Psychology
Physicians
Defense Mechanisms
2013
Monoclonal Gammopathy of Undetermined Significance
Immunoglobulin Heavy Chain Genes
Waldenstrom Macroglobulinemia
Gene Rearrangement
Immunoglobulin M
fotemustine
Multiple Myeloma
Dexamethasone
Alkylating Agents
Disease-Free Survival

Long Term Evaluation of the Impact of Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: A Cost-Effectiveness Analysis

Corso, A., Mangiacavalli, S., Cocito, F., Pascutto, C., Ferretti, V. V., Pompa, A., Ciampichini, R., Pochintesta, L. & Mantovani, L. G., Sep 30 2013, In : PLoS One. 8, 9, e75047.

Research output: Contribution to journalArticle

Peripheral Blood Stem Cell Transplantation
cell transplantation
myeloma
cost effectiveness
Cost effectiveness

Monoclonal gammopathy of undetermined significance: A new proposal of workup

Mangiacavalli, S., Cocito, F., Pochintesta, L., Pascutto, C., Ferretti, V., Varettoni, M., Zappasodi, P., Pompa, A., Landini, B., Cazzola, M. & Corso, A., Oct 2013, In : European Journal of Haematology. 91, 4, p. 356-360 5 p.

Research output: Contribution to journalArticle

Monoclonal Gammopathy of Undetermined Significance
Multiple Myeloma
Hematology
Plasma Cells
Bone Marrow Cells
Waldenstrom Macroglobulinemia
Monoclonal Gammopathy of Undetermined Significance
Immunoglobulin M
Mutation
Neoplasms
2012
Multiple Myeloma
Disease-Free Survival
Transplants
Autografts
Proportional Hazards Models

Risk of second cancers in Waldenström macroglobulinemia

Varettoni, M., Tedeschi, A., Arcaini, L., Pascutto, C., Vismara, E., Orlandi, E., Ricci, F., Corso, A., Greco, A., Mangiacavalli, S., Lazzarino, M. & Morra, E., Feb 2012, In : Annals of Oncology. 23, 2, p. 411-415 5 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Second Primary Neoplasms
Incidence
Hematologic Neoplasms
Lymphoproliferative Disorders

Similar neurotoxicity of an alternating compared to a continuous low-dose schedule of thalidomide for relapsed/refractory multiple myeloma

Mangiacavalli, S., Albani, G., Caravita, T., Cocito, F., Pascutto, C., Zappasodi, P., Bringhen, S., Palumbo, A., Cazzola, M. & Corso, A., Mar 2012, In : Leukemia and Lymphoma. 53, 3, p. 514-515 2 p.

Research output: Contribution to journalArticle

2010
Peripheral Nervous System Diseases
Multiple Myeloma
Neuralgia
Incidence
Bortezomib

Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma

Corso, A., Barbarano, L., Mangiacavalli, S., Spriano, M., Alessandrino, E. P., Cafro, A. M., Pascutto, C., Varettoni, M., Bernasconi, P., Grillo, G., Carella, A. M., Montalbetti, L., Lazzarino, M. & Morra, E., Feb 2010, In : Leukemia and Lymphoma. 51, 2, p. 236-242 7 p.

Research output: Contribution to journalArticle

Autografts
Dexamethasone
Stem Cells
Drug Therapy
Etoposide

Changing pattern of presentation in monoclonal gammopathy of undetermined significance: A single-center experience with 1400 patients

Varettoni, M., Corso, A., Cocito, F., Mangiacavalli, S., Pascutto, C., Zappasodi, P., Pica, G. & Lazzarino, M., Jul 2010, In : Medicine (United States). 89, 4, p. 211-216 6 p.

Research output: Contribution to journalArticle

Monoclonal Gammopathy of Undetermined Significance
Plasma Cells
Bone Marrow Cells
Immunoglobulin M
Albumins

Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: A longitudinal study on 1003 consecutive patients

Varettoni, M., Corso, A., Pica, G., Mangiacavalli, S., Pascutto, C. & Lazzarino, M., Feb 2010, In : Annals of Oncology. 21, 2, p. 325-330 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Longitudinal Studies
Incidence
Therapeutics
Thalidomide
2009

A striking response to bortezomib in a patient with pleural localization of multiple myeloma

Mangiacavalli, S., Varettoni, M., Zappasodi, P., Pica, G., Lazzarino, M. & Corso, A., Apr 2009, In : Leukemia Research. 33, 4, p. 577-578 2 p.

Research output: Contribution to journalArticle

Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-lived

Corso, A., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Pica, G. M., Algarotti, A., Pascutto, C. & Lazzarino, M., Nov 2009, In : European Journal of Haematology. 83, 5, p. 449-454 6 p.

Research output: Contribution to journalArticle

Dexamethasone
Peripheral Nervous System Diseases
Multiple Myeloma
Bortezomib
Therapeutics

Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients

Mangiacavalli, S., Pica, G., Varettoni, M., Lazzarino, M. & Corso, A., Mar 2009, In : European Journal of Haematology. 82, 3, p. 240-241 2 p.

Research output: Contribution to journalArticle

Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects

Corso, A., Zappasodi, P., Barbarano, L., Petrucci, M. T., Palumbo, A., Caravita, T., Mangiacavalli, S., Cafro, A. M., Varettoni, M., Gay, F., Morra, E. & Lazzarino, M., Sep 2009, In : Leukemia Research. 33, 9

Research output: Contribution to journalArticle

Thalidomide
Multiple Myeloma
Steroids
Constipation
Survival
2008

DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients

Zappasodi, P., Nosari, A. M., Astori, C., Ciapanna, D., Bonfichi, M., Varettoni, M., Mangiacavalli, S., Morra, E., Lazzarino, M. & Corso, A., May 2008, In : Transfusion. 48, 5, p. 857-860 4 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Multiple Myeloma
Leukapheresis
Drug Therapy
Body Weight

Efficacy of Bortezomib followed by local irradiation in two patients with extramedullary plasmacytomas

Varettoni, M., Mangiacavalli, S., Zappasodi, P., Pica, G. M., Lazzarino, M. & Corso, A., May 2008, In : Leukemia Research. 32, 5, p. 841-843 3 p.

Research output: Contribution to journalArticle

Efficacy of Bortezomib followed by local irradiation in two patients with extramedullary plasmacytomas.

Varettoni, M., Mangiacavalli, S., Zappasodi, P., Pica, G. M., Lazzarino, M. & Corso, A., May 2008, In : Leukemia Research. 32, 5, p. 839-841 3 p.

Research output: Contribution to journalArticle

Immune-mediated neuropathies in myeloma patients treated with bortezomib

Ravaglia, S., Corso, A., Piccolo, G., Lozza, A., Alfonsi, E., Mangiacavalli, S., Varettoni, M., Zappasodi, P., Moglia, A., Lazzarino, M. & Costa, A., Nov 2008, In : Clinical Neurophysiology. 119, 11, p. 2507-2512 6 p.

Research output: Contribution to journalArticle

Poisons
Peripheral Nervous System Diseases
Therapeutic Uses
Proteasome Endopeptidase Complex
Therapeutics

Infiltration of the spinal cord in a patient with multiple myeloma

Varettoni, M., Corso, A., Zappasodi, P., Calliada, F., Castagnola, C., Mangiacavalli, S. & Lazzarino, M., 2008, In : Journal of Clinical Oncology. 26, 25, p. 4207-4209 3 p.

Research output: Contribution to journalArticle

Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapy

Corso, A., Mangiacavalli, S., Barbarano, L., Montalbetti, L., Mazzone, A., Fava, S., Varettoni, M., Zappasodi, P., Morra, E. & Lazzarino, M., Jul 2008, In : Leukemia Research. 32, 7, p. 1085-1090 6 p.

Research output: Contribution to journalArticle

Thalidomide
Multiple Myeloma
Dexamethasone
Transplants
Melphalan

The place of thalidomide in the treatment of multiple myeloma

Corso, A. & Mangiacavalli, S., Feb 2008, In : Oncology Reviews. 1, 4, p. 205-214 10 p.

Research output: Contribution to journalArticle

Thalidomide
Multiple Myeloma
Pharmaceutical Preparations
Drug Therapy
Biological Factors
2007
zoledronic acid
Osteonecrosis
Jaw
pamidronate
Multiple Myeloma

Late onset of bortezomib-associated cutaneous reaction following herpes zoster [4]

Varettoni, M., Vassallo, C., Borroni, G., Mangiacavalli, S., Zappasodi, P., Rosso, R., Lazzarino, M. & Corso, A., Apr 2007, In : Annals of Hematology. 86, 4, p. 301-302 2 p.

Research output: Contribution to journalArticle

Limited feasibility of double transplant in multiple myeloma: Results of a multicenter study on 153 patients aged

Corso, A., Mangiacavalli, S., Barbarano, L., Alessandrino, E. P., Cairoli, R., Morra, E. & Laziarino, M., Jun 1 2007, In : Cancer. 109, 11, p. 2273-2278 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Multicenter Studies
Transplants
Lost to Follow-Up
Autografts

Severe intestinal vasculitis in a patient under treatment with bortezomib

Mangiacavalli, S., Zappasodi, P., Castagnola, C., Astori, C., Varettoni, M., Lazzarino, M. & Corso, A., 2007, In : Annals of Hematology. 86, 12, p. 923-924 2 p.

Research output: Contribution to journalArticle

2006

Bortezomib in newly diagnosed multiple myeloma patients

Mangiacavalli, S., 2006, In : Haematologica Reports. 2, 5, p. 8-10 3 p.

Research output: Contribution to journalArticle